The Supreme Court's Week: By The Numbers
The U.S. Supreme Court heard arguments in just three cases this week, but two of them were highly anticipated ones that addressed whether Purdue Pharma's Chapter 11 plan can include a...To view the full article, register now.
Already a subscriber? Click here to view full article